Lecanemab 的售價：每位患者每年 26,500 美元！ 01/14/23 SaturdayBy Tokio X'press Alzheimer, FDA, Medical science, Pharmaceutical 美国 FDA：武田制药的肺癌治疗批准：Exkivity 09/26/21 SundayBy Tokio X'press Cancer, FDA, Pharmaceutical COVID-19：FDA 紧急授予“Actemra”：降低死亡率 07/01/21 ThursdayBy Tokio X'press flu, FDA, Pharmaceutical 大规模的WHO remdesivir研究表明Covid-19无益处 10/22/20 ThursdayBy Tokio X'press flu, FDA, Pharmaceutical COVID-19：欧盟，伦贝西比供应合同：需要审核吗？ 10/22/20 ThursdayBy Tokio X'press flu, FDA, Pharmaceutical Posts navigation Page 1 Page 2 … Page 11
